Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
- DOI
- 10.1038/sj.bjp.0705419
- Published
- 2003 Sep
- Container
- British journal of pharmacology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
serious concern Score 27/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- serious concernRetraction Watch expression of concern: 1 expression of concern notice matched this DOI.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/sj.bjp.0705419,
title = {Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.},
author = {Cuzzocrea S and Pisano B and Dugo L and Ianaro A and Patel NS and Di Paola R and Genovese T and Chatterjee PK and Di Rosa M and Caputi AP and Thiemermann C},
year = {2003},
journal = {British journal of pharmacology},
doi = {10.1038/sj.bjp.0705419},
url = {https://doi.org/10.1038/sj.bjp.0705419}
}RIS
TY - JOUR TI - Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut. AU - Cuzzocrea S AU - Pisano B AU - Dugo L AU - Ianaro A AU - Patel NS AU - Di Paola R AU - Genovese T AU - Chatterjee PK AU - Di Rosa M AU - Caputi AP AU - Thiemermann C PY - 2003 JO - British journal of pharmacology DO - 10.1038/sj.bjp.0705419 UR - https://doi.org/10.1038/sj.bjp.0705419 ER -
APA
S, C., B, P., L, D., A, I., NS, P., R, D. P., T, G., PK, C., M, D. R., AP, C., & C, T. (2003). Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.. British journal of pharmacology. https://doi.org/10.1038/sj.bjp.0705419
Source records
- pubmed · retrieved 2026-09-24T23:15:18.624Z
- europe-pmc · retrieved 2026-09-24T23:15:18.611Z